McKinsey Advised Both Pharma Clients and Regulators

New York Times: “A review by The New York Times of thousands of internal McKinsey documents found that the firm repeatedly allowed employees who served pharmaceutical companies, including opioid makers, to also consult for the FDA, the drug industry’s primary government regulator.”

“And, the documents show, McKinsey touted that inside access in pitches to private clients. In an email in 2014 to Purdue’s chief executive, a McKinsey consultant highlighted the firm’s work for the FDA and stressed ‘who we know and what we know.'”